Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Medications only deliver benefits when people actually take them consistently without skipping doses regularly, and oral formulations remove barriers that cause patients to discontinue treatment prematurely
Common side effects are gastrointestinal issues such as nausea, vomiting, diarrhoea, and acid reflux
8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes
The authors apologize to researchers whose relevant work could not be cited in the present review owing to space limitations
IV and injected forms carry higher risk and need medical oversight
Managing Side Effects: Gradual Initiation: Start with a low dose, gradually increasing it as tolerated
US$ 26.90
US$ 21.75
US$ 22.23
US$ 26.95
US$ 28.54
US$ 26.86
US$ 27.36
US$ 24.09
US$ 28.71
US$ 22.62
